TARS
Tarsus Pharmaceuticals, Inc.When TARS passed all Ten ChecksTarsus Pharmaceuticals, Inc.
history · not a forecastOver the past 10 years, TARS has passed all Ten Checks on 2 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +19.1% in Oct 2025, peaked day 17.
- Oct 2025+19.1% -1.3%
- Nov 2024+14.8% +4.0%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about TARS’s checks
How many technical checks does TARS pass right now?
As of the Oct 23, 2026 close, TARS passes 5 of 10 fixed technical checks — the checks not passing: market trend rising, holding above short-term average, outperforming the market, stop distance within range, adequate stop room.
Why does TARS fail the "holding above short-term average" check?
TARS closed at $68.20, 3.6% below its 9-day average ($70.72), so this momentum check fails. It passes again on a close above $70.72.
What price would change TARS's check count?
The nearest flip level is "stop distance within range" passes on a close between $69.02 – $73.52. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.